Culwell Kelly

Avg. Two Year Performance

39% Avg. Purchase Return
18% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return63%52%52%122%39%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return11%30%44%22%0%
Sale Success Rate2 of 33 of 33 of 31 of 30 of 3
Drugs » Biotechnology

Chief Medical Officer:

Holdings: 273.39K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--